Edgewise Therapeutics, Inc. ( EWTX) - Stock Earnings
EWTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -40.7 million USD | — USD |
| 2025Q4 | -50.2 million USD | — USD |
| 2026Q1 | -49.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
EWTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.2 million USD | — USD |
| 2024 | -133.8 million USD | — USD |
| 2025 | -167.8 million USD | — USD |
| 2026 Est. | — | — |
EWTX
Price: $35.21
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 74985
Market Capitalization: 4.0 billion